Warhound Raises $200 Million to Develop Gene-Edited Military Canines
A new venture backed by tech and defense leaders is investing heavily in cloning high-performance dogs with genetic modifications to reduce common health issues.
By Ken Adams ·
The U.S. military may soon receive a new class of working dogs that are not only trained for specific tasks but also genetically optimized for longevity and health. A new startup named Warhound has secured $200 million in funding to begin producing these animals, marking a significant shift in how service animals are developed for defense and first responder roles.
The venture is a joint effort between Ben Lamm of Colossal Biosciences and Palmer Luckey, the founder of Anduril. While the project involves cutting-edge genetic technology, the immediate goal is not to create cyborgs but to enhance the biological resilience of existing breeds. The company aims to reduce the prevalence of hereditary conditions that often shorten the careers of high-performing military and police dogs.
Warhound has already initiated the genetic editing process on cell samples from its first group of donor animals. These samples were collected from top-performing dogs across the United States, primarily Belgian Malinois, with some contributions from Labradors and Shepherds. Scientists from Colossal Biosciences will modify the genes of these samples before cloning the animals, ensuring that the next generation inherits improved traits.
The initial focus of the research is on mitigating health risks common to these breeds, such as hip dysplasia and certain types of cancer. Lamm indicated that future enhancements could include genetic changes designed to increase speed, agility, or olfactory sensitivity. This phased approach allows the company to address critical health concerns before pursuing more complex performance-based modifications.
The founders bring distinct backgrounds to the project. Luckey, known for founding Oculus VR and designing the Rift headset, leads Anduril, a defense technology company. Anduril recently won a U.S. Army contract to build a next-generation battlefield intelligence system alongside Palantir. Lamm’s company, Colossal Biosciences, is recognized for its de-extinction efforts, including projects to revive the dire wolf and the woolly mammoth.
Anduril’s involvement in Warhound is strictly focused on equipment and software rather than biology. The company will design protective gear for the dogs, including goggles, vests, and body armor. This division of labor ensures that while the animals are biologically optimized, they are also equipped with advanced tools to protect them during field operations.
The ownership structure of the company differs from its public partnership profile. While Luckey is a partner in the business, neither he nor Anduril holds an equity stake in Warhound. Colossal Biosciences does hold equity, and Lamm serves on the company’s board. The role of Chief Executive Officer is held by David Spirk, who previously worked at Palantir.
The first batch of these genetically engineered dogs is expected to be born in early 2027. Once born, the animals will undergo training for standard working dog duties, such as bomb detection and search-and-rescue operations. This timeline suggests that the initial results of the program will be available for evaluation in the coming year.
Source: Engadget
